Does DARATUMUMAB Cause Plasma cell myeloma refractory? 404 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 404 reports of Plasma cell myeloma refractory have been filed in association with DARATUMUMAB (DARZALEX). This represents 1.5% of all adverse event reports for DARATUMUMAB.
404
Reports of Plasma cell myeloma refractory with DARATUMUMAB
1.5%
of all DARATUMUMAB reports
31
Deaths
26
Hospitalizations
How Dangerous Is Plasma cell myeloma refractory From DARATUMUMAB?
Of the 404 reports, 31 (7.7%) resulted in death, 26 (6.4%) required hospitalization, and 12 (3.0%) were considered life-threatening.
Is Plasma cell myeloma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 404 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Plasma cell myeloma refractory?
BORTEZOMIB (618)
DEXAMETHASONE (513)
LENALIDOMIDE (489)
CARFILZOMIB (386)
POMALIDOMIDE (280)
CYCLOPHOSPHAMIDE (237)
IXAZOMIB (132)
DOXORUBICIN (115)
ETOPOSIDE (90)
THALIDOMIDE (89)
Which DARATUMUMAB Alternatives Have Lower Plasma cell myeloma refractory Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE